• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氢/氘交换质谱分析揭示了纤溶酶原激活物抑制剂 1 与玻连蛋白 somatomedin B 结构域结合时局部柔性的特异性变化。

Hydrogen/deuterium exchange mass spectrometry reveals specific changes in the local flexibility of plasminogen activator inhibitor 1 upon binding to the somatomedin B domain of vitronectin.

机构信息

Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark.

出版信息

Biochemistry. 2012 Oct 16;51(41):8256-66. doi: 10.1021/bi3008998. Epub 2012 Oct 4.

DOI:10.1021/bi3008998
PMID:22957734
Abstract

The native fold of plasminogen activator inhibitor 1 (PAI-1) represents an active metastable conformation that spontaneously converts to an inactive latent form. Binding of the somatomedin B domain (SMB) of the endogenous cofactor vitronectin to PAI-1 delays the transition to the latent state and increases the thermal stability of the protein dramatically. We have used hydrogen/deuterium exchange mass spectrometry to assess the inherent structural flexibility of PAI-1 and to monitor the changes induced by SMB binding. Our data show that the PAI-1 core consisting of β-sheet B is rather protected against exchange with the solvent, while the remainder of the molecule is more dynamic. SMB binding causes a pronounced and widespread stabilization of PAI-1 that is not confined to the binding interface with SMB. We further explored the local structural flexibility in a mutationally stabilized PAI-1 variant (14-1B) as well as the effect of stabilizing antibody Mab-1 on wild-type PAI-1. The three modes of stabilizing PAI-1 (SMB, Mab-1, and the mutations in 14-1B) all cause a delayed latency transition, and this effect was accompanied by unique signatures on the flexibility of PAI-1. Reduced flexibility in the region around helices B, C, and I was seen in all three cases, which suggests an involvement of this region in mediating structural flexibility necessary for the latency transition. These data therefore add considerable depth to our current understanding of the local structural flexibility in PAI-1 and provide novel indications of regions that may affect the functional stability of PAI-1.

摘要

纤溶酶原激活物抑制剂 1(PAI-1)的天然折叠结构代表一种活性亚稳态构象,其可自发转化为无活性的潜伏形式。内源性辅因子纤连蛋白的 somatomedin B 结构域(SMB)与 PAI-1 的结合可延迟向潜伏状态的转变,并显著增加蛋白质的热稳定性。我们使用氢/氘交换质谱法来评估 PAI-1 的固有结构灵活性,并监测 SMB 结合所诱导的变化。我们的数据表明,由β-折叠 B 组成的 PAI-1 核心对与溶剂的交换具有较强的保护作用,而分子的其余部分则更为动态。SMB 结合导致 PAI-1 明显且广泛的稳定化,这种稳定化作用不仅局限于 SMB 与 PAI-1 的结合界面。我们进一步研究了突变稳定化 PAI-1 变体(14-1B)中的局部结构灵活性,以及稳定化抗体 Mab-1 对野生型 PAI-1 的影响。稳定化 PAI-1 的三种方式(SMB、Mab-1 和 14-1B 中的突变)均导致潜伏期转变延迟,这种效应伴随着 PAI-1 灵活性的独特特征。在这三种情况下,均观察到围绕螺旋 B、C 和 I 的区域的灵活性降低,这表明该区域参与介导潜伏期转变所需的结构灵活性。因此,这些数据为我们当前对 PAI-1 局部结构灵活性的理解增添了新的认识,并提供了可能影响 PAI-1 功能稳定性的区域的新迹象。

相似文献

1
Hydrogen/deuterium exchange mass spectrometry reveals specific changes in the local flexibility of plasminogen activator inhibitor 1 upon binding to the somatomedin B domain of vitronectin.氢/氘交换质谱分析揭示了纤溶酶原激活物抑制剂 1 与玻连蛋白 somatomedin B 结构域结合时局部柔性的特异性变化。
Biochemistry. 2012 Oct 16;51(41):8256-66. doi: 10.1021/bi3008998. Epub 2012 Oct 4.
2
Copper(II) Ions Increase Plasminogen Activator Inhibitor Type 1 Dynamics in Key Structural Regions That Govern Stability.铜(II)离子增加了1型纤溶酶原激活物抑制剂在决定稳定性的关键结构区域的动力学。
Biochemistry. 2016 Aug 9;55(31):4386-98. doi: 10.1021/acs.biochem.6b00256. Epub 2016 Jul 27.
3
Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangements.纤溶酶原激活物抑制剂-1 与 vitronectin 的相互作用涉及广泛的结合表面,并诱导相互构象重排。
Biochemistry. 2009 Mar 3;48(8):1723-35. doi: 10.1021/bi8017015.
4
Functional structure of the somatomedin B domain of vitronectin.玻连蛋白生长调节素B结构域的功能结构
Protein Sci. 2007 Jul;16(7):1502-8. doi: 10.1110/ps.072819107. Epub 2007 Jun 13.
5
A method for defining binding sites involved in protein-protein interactions: analysis of the binding of plasminogen activator inhibitor 1 to the somatomedin domain of vitronectin.一种确定蛋白质-蛋白质相互作用中涉及的结合位点的方法:纤溶酶原激活物抑制剂1与玻连蛋白生长调节素结构域结合的分析
Anal Biochem. 2001 Sep 15;296(2):245-53. doi: 10.1006/abio.2001.5316.
6
The reduced, denatured somatomedin B domain of vitronectin refolds into a stable, biologically active molecule.纤连蛋白减少、变性的生长调节素B结构域可重新折叠成稳定的生物活性分子。
Biochemistry. 2006 Mar 14;45(10):3297-306. doi: 10.1021/bi052278f.
7
Dissecting the effect of RNA aptamer binding on the dynamics of plasminogen activator inhibitor 1 using hydrogen/deuterium exchange mass spectrometry.利用氢/氘交换质谱法解析 RNA 适体结合对纤溶酶原激活物抑制剂 1 动力学的影响。
ACS Chem Biol. 2014 Jan 17;9(1):174-82. doi: 10.1021/cb400619v. Epub 2013 Nov 14.
8
Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin.纤溶酶原激活物抑制剂-1通过与玻连蛋白的生长调节素B结构域结合来调节细胞黏附。
J Cell Physiol. 2001 Oct;189(1):23-33. doi: 10.1002/jcp.1133.
9
Solution structure of recombinant somatomedin B domain from vitronectin produced in Pichia pastoris.在毕赤酵母中产生的玻连蛋白重组生长调节素B结构域的溶液结构
Protein Sci. 2007 Sep;16(9):1934-45. doi: 10.1110/ps.072949607.
10
Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.噬菌体展示的高突变纤溶酶原激活物抑制剂1(PAI-1)文库证明,潜伏期转变和蛋白酶抑制过程中PAI-1的不同结构要求。
J Mol Biol. 2001 Jan 26;305(4):773-83. doi: 10.1006/jmbi.2000.4356.

引用本文的文献

1
Strand 1A variant in neuroserpin shows increased aggregation and no loss of inhibition: implication in ameliorating polymerization to retain activity.神经丝氨酸蛋白酶抑制剂 1A 变异体显示出增加的聚集而没有抑制丧失:改善聚合以保留活性的意义。
Biosci Rep. 2022 Dec 22;42(12). doi: 10.1042/BSR20221825.
2
Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484.小分子 TM5484 抑制 PAI-1 的两步机制的结构洞察。
Int J Mol Sci. 2021 Feb 2;22(3):1482. doi: 10.3390/ijms22031482.
3
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition.
心血管疾病中靶向纤溶酶原激活物抑制剂-1:纤溶酶原激活物抑制剂-1功能及抑制作用的结构见解
Front Cardiovasc Med. 2020 Dec 22;7:622473. doi: 10.3389/fcvm.2020.622473. eCollection 2020.
4
Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1/plasminogen activator interaction.两种抑制纤溶酶原激活物抑制剂-1(PAI-1)活性的纳米抗体的分子机制揭示了PAI-1/纤溶酶原激活剂相互作用不同阶段的调节作用。
J Thromb Haemost. 2020 Mar;18(3):681-692. doi: 10.1111/jth.14716. Epub 2020 Feb 20.
5
HDX-MS reveals orthosteric and allosteric changes in apolipoprotein-D structural dynamics upon binding of progesterone.HDX-MS 揭示了载脂蛋白-D 结构动力学在与孕酮结合时的变构和变构变化。
Protein Sci. 2019 Feb;28(2):365-374. doi: 10.1002/pro.3534. Epub 2018 Dec 20.
6
Resolving distinct molecular origins for copper effects on PAI-1.解析铜对纤溶酶原激活物抑制因子-1作用的不同分子起源。
J Biol Inorg Chem. 2017 Oct;22(7):1123-1135. doi: 10.1007/s00775-017-1489-5. Epub 2017 Sep 14.
7
Conformational preludes to the latency transition in PAI-1 as determined by atomistic computer simulations and hydrogen/deuterium-exchange mass spectrometry.原子模拟计算和氘代/氢交换质谱法测定的 PAI-1 潜伏态转变的构象前序。
Sci Rep. 2017 Jul 26;7(1):6636. doi: 10.1038/s41598-017-06290-0.
8
Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.活性中心环构象和动力学变化揭示了纤溶酶原激活物抑制剂-1(PAI-1)与纤溶酶原激活物及玻连蛋白形成的不同结合复合物。
Protein Sci. 2016 Feb;25(2):499-510. doi: 10.1002/pro.2841. Epub 2015 Dec 2.
9
Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.止血和静脉功能不全中的临时基质沉积:非愈合性静脉溃疡的组织预处理
Adv Wound Care (New Rochelle). 2015 Mar 1;4(3):174-191. doi: 10.1089/wound.2013.0462.
10
Applications of hydrogen/deuterium exchange MS from 2012 to 2014.2012年至2014年氢/氘交换质谱的应用。
Anal Chem. 2015 Jan 6;87(1):99-118. doi: 10.1021/ac5040242. Epub 2014 Nov 14.